Compare EPAM Systems Inc (EPAM) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EPAM Systems Inc vs Oscar Health Inc — how do they compare? EPAM Systems Inc trades at $113.24 (market cap $5.87B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Oscar Health Inc is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, EPAM Systems Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EPAM Systems Inc for 37 Days and Oscar Health Inc for 15 Days on average.
| EPAM | OSCR | |
|---|---|---|
Market Cap | $5.87B | $10.22B |
Volume | 847,420 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $221.40 | $33.81 |
52-Week Low | $76.04 | $10.85 |
Typical Hold Time | 37 Days | 15 Days |
Enterprise Value | $5.24B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EPAM Systems trades at $113.86, up 5.11% today, with strong technical momentum as the stock approaches resistance near $115. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $5.46B in 2025, though net margins compressed to 6.92%. Recent news highlights EPAM's cloud infrastructure achievements and activist investor pressure for share buybacks.
The outlook remains cautiously optimistic with a consensus price target of $119 offering 4.5% upside. Key risks include North American growth slowdown and AI disruption to legacy services. Analyst sentiment is predominantly bullish (59% Buy ratings), but investors should monitor Q3 earnings and management's response to shareholder value concerns.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EPAM Systems Inc
EPAM Systems Inc provides software product development and digital platform engineering services to clients located around the world. The company services include Software Product Development, Custom Application Development, Application Testing, Enterprise Application Platforms, Application Maintenance, and Support and Infrastructure Management. The company focuses on innovative and scalable software solutions. The company uses industry standard and custom developed technology, tools, and platforms to deliver results to handle business challenges. The company primarily offers its solutions in the following industries: financial services, travel and consumer, software and hi-tech, life sciences and healthcare. The majority of revenue is generated from North American clients.
Read more on EPAM →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
